ATRC vs. TFX, ITGR, ATEC, IART, SRDX, ANGO, OFIX, ARAY, RMTI, and RSLS
Should you be buying AtriCure stock or one of its competitors? The main competitors of AtriCure include Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), Integra LifeSciences (IART), Surmodics (SRDX), AngioDynamics (ANGO), Orthofix Medical (OFIX), Accuray (ARAY), Rockwell Medical (RMTI), and ReShape Lifesciences (RSLS). These companies are all part of the "health care equipment" industry.
AtriCure vs. Its Competitors
AtriCure (NASDAQ:ATRC) and Teleflex (NYSE:TFX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.
99.1% of AtriCure shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 3.5% of AtriCure shares are owned by insiders. Comparatively, 1.4% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
AtriCure presently has a consensus target price of $50.67, indicating a potential upside of 61.41%. Teleflex has a consensus target price of $164.63, indicating a potential upside of 35.61%. Given AtriCure's stronger consensus rating and higher possible upside, equities analysts clearly believe AtriCure is more favorable than Teleflex.
Teleflex has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.
AtriCure has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.
Teleflex has a net margin of 4.96% compared to AtriCure's net margin of -7.95%. Teleflex's return on equity of 14.73% beat AtriCure's return on equity.
In the previous week, Teleflex had 16 more articles in the media than AtriCure. MarketBeat recorded 19 mentions for Teleflex and 3 mentions for AtriCure. AtriCure's average media sentiment score of 1.44 beat Teleflex's score of 0.36 indicating that AtriCure is being referred to more favorably in the media.
Summary
AtriCure and Teleflex tied by winning 8 of the 16 factors compared between the two stocks.
Get AtriCure News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AtriCure Competitors List
Related Companies and Tools
This page (NASDAQ:ATRC) was last updated on 7/2/2025 by MarketBeat.com Staff
Free ATRC Stock Alerts